02415 MEDSCI
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 7.36X | Oper Margin | 9.8% |
|---|---|---|---|
| LT Debt/Equity | 0.0% | Net Margin | 9.6% |
| Total Debt/Equity | 0.2% | Return on Equity | 2.1% |
| Price/Book | 0.65X | Return on Assets | 1.9% |
| (HKD 1.330) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 26.55 | 60.67 | -111.99 | -184.72 | 34.32 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -56.2 | +154.2 | +39.4 | -638.3 | N/A |
| Earnings Per Share (HKD) | 0.049 | 0.117 | -0.237 | -21.572 | 3.593 |
| Earnings Per Share Growth (%) | -58.1 | +149.4 | +98.9 | -700.5 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 27.09 | 11.36 | N/A | N/A | 0.37 |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 2.049 | 2.034 | N/A | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 260.623 | 349.194 | -25.4 | 348.95 |
| Operating Result | 25.497 | 60.45 | -57.8 | -96.292 |
| Profit Before Taxation | 25.497 | 60.45 | -57.8 | -96.292 |
| Taxation | 0.53 | 5.408 | -90.2 | 3.589 |
| Profit /( Loss) After Taxation | 24.967 | 55.042 | -54.6 | -99.881 |
| Net Profit | 24.967 | 55.042 | -54.6 | -99.881 |
| Earnings Per Share () | 0.0491 | 0.1171 | -58.1 | -0.2370 |
| Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-04-17 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
